Market Overview

Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims

Share:
Related AGN
5 Manufacturing Stocks With 25% Upside Potential
The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know
Teva's Got Potential - And The Complexity To Go With It (Seeking Alpha)
Related VRX
Donald Trump Has Become To Aerospace What Hillary Clinton Was To Pharma
Trump: Drug Industry Is 'Getting Away With Murder'
Did Martin Shkreli Kill Mallinckrodt's Business Model? (Seeking Alpha)

Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today filed an answer
in the United States District Court for the Central District of California
responding to Valeant Pharmaceuticals International, Inc. (“Valeant”) and
Pershing Square Capital Management, L.P.'s (“Pershing Square”) counterclaims
regarding Allergan's statements on the unsustainability of Valeant's
underlying business model.

The federal court case is Allergan, Inc. v. Valeant Pharmaceuticals
International, Inc., No. 14-CV-1214-DOC (ANx) (C.D. Cal.).

Posted-In: News Hedge Funds Legal Press Releases General

 

Related Articles (AGN + VRX)

View Comments and Join the Discussion!